Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2026

Key Benefits

✔ Save Significant Research Time
Access a comprehensive database of option and evaluation deals instead of searching multiple databases, press releases, and regulatory filings.

✔ Benchmark Option and Evaluation Deal Structures
Understand how pharmaceutical and biotechnology companies structure option-based partnerships, including evaluation rights, development options, and licensing pathways.

✔ Analyze Financial Terms with Confidence
Review disclosed payment structures and deal terms to benchmark the financial value and structure of comparable option transactions.

✔ Access Real Contract Documents
Where available, explore actual option and evaluation agreements filed with the SEC, providing deeper insight into the contractual provisions behind real-world deals.

✔ Identify the Most Active Option Dealmakers
Discover which companies are most active in option-based partnerships and analyze their strategic partnering activity.

✔ Track Industry Trends
Analyze option and evaluation dealmaking trends since 2019 across companies, therapeutic areas, and technology types.

Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Trends in option and evaluation dealmaking

2.1. Introduction

2.2. Definition of option and evaluation deal

2.3. Trends in option and evaluation deals since 2019

2.3.1. Option and evaluation dealmaking by year

2.3.2. Option and evaluation dealmaking by phase of development

2.3.3. Option and evaluation dealmaking by industry sector

2.3.4. Option and evaluation dealmaking by therapy area

2.3.5. Option and evaluation dealmaking by technology type

2.3.6. Option and evaluation dealmaking by most active company

2.4. Reasons for entering into option and evaluation partnering deals

2.5. The future of option and evaluation deals

 

Chapter 3 – Overview of option and evaluation deal structure

3.1. Introduction

3.2. Option and evaluation agreement structure

 

Chapter 4 – Leading option and evaluation deals

4.1. Introduction

4.2. Top option and evaluation deals by value

 

Chapter 5 – Top 25 most active option and evaluation dealmakers

5.1. Introduction

5.2. Top 25 most active option and evaluation dealmakers

 

Chapter 6 – option and evaluation deals including contracts directory

6.1. Introduction

6.2. Option and evaluation deals with contracts

 

Deal directory

Deal directory – option and evaluation dealmaking by companies A-Z

Deal directory – option and evaluation dealmaking by therapy area

Deal directory – option and evaluation dealmaking by technology type

 

About Biopharma Research Ltd

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

TABLE OF FIGURES

Figure 1: Definition of option and evaluation

Figure 2: Trends in option and evaluation deal announcements

Figure 3: Option and evaluation deals signed at each phase of development

Figure 4: Option and evaluation deals by industry sector

Figure 5: Option and evaluation deals by therapy area

Figure 6: Option and evaluation deals by technology type

Figure 7: Top 25 most active option and evaluation dealmakers

Figure 8: Top option and evaluation deals by value

Figure 9: Most active option and evaluation dealmakers

Pricing options

• $3,995: single-user (encrypted file - one user/device)
• $5,995: multi-user (encrypted file - up to 5 users/devices)
• $7,995: company (unencrypted file)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

 

Total Trust

Current Partnering is part of Biopharma Research Ltd based in County Durham, United Kingdom. We have been trading successfully online since 2012 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

2cureX, 2seventy bio, 3B Pharmaceuticals, 3D Medicines, 3SBio, 3T Biosciences, 4D Molecular Therapeutics, 4D Pharma, 9 Meters Biopharma, 23andMe, 48Hour Discovery, A2 Biotherapeutics, A2A Pharmaceuticals, Aarvik Therapeutics, AB2 Bio, Abbisko Therapeutics, Abbott Laboratories, Abbvie, AbCellera Biologics, Abeona Therapeutics, Abera Bioscience, Abilita Therapeutics, Ablaze Pharmaceuticals, AbSci, Accent Therapeutics, Acelyrin, Acepodia, Acer Therapeutics, Ache, Achilles Therapeutics, AC Immune, Acuitas Therapeutics, Acumen Pharmaceuticals, Acutus Medical, Adagene, Adaptimmune, Adaptive Phage Therapeutics, AdaptVac, ADARx Pharmaceuticals, Adcendo, ADC Therapeutics, Addario Lung Cancer Medical Institute, Addex Therapeutics, Adeptrix, Adhera Therapeutics, Adimab, Aditum Bio, AdoRx Therapeutics, ADT Pharmaceuticals, Advaite, Advancium Health Network, Aegea Biotechnologies, Aelis Pharma, Aequus Pharmaceuticals, Aerpio Pharmaceuticals, Aethon Therapeutics, Aevi Genomic Medicine, Aexon Labs, Affibody, Affini-T Therapeutics, Affinia Therapeutics, AFT Pharmaceuticals, Agenus Bio, AgeX Therapeutics, AgNovos Healthcare, AIkido Pharma, Aileron Therapeutics, Ainos, AI Proteins, Aitia, Ajinomoto, AJU Pharma, Akcea Therapeutics, Akebia Therapeutics, Akero Therapeutics, Akston Biosciences, Aldeyra Therapeutics, Alector, Alexion Pharmaceuticals, Alfasigma, Aligos Therapeutics, AlivaMab Discovery Services, AliveCor, Alivio Therapeutics, Alkyon Therapeutics, Allarity Therapeutics, Allegro Ophthalmics, Allergan, Allergan Aesthetics, Alligator Bioscience, Allist Pharma, Allogene Therapeutics, Allorion Therapeutics, Almirall, Alnylam Pharmaceuticals, Alphageneron Pharmaceuticals, Alpine Immune Sciences, Altamira Therapeutics, Altavant Sciences, Alternavida, Alumis, Alverno Clinical Laboratories, AmacaThera, Amagma Therapeutics, Amasa Therapeutics, Amathus Therapeutics, Amerimmune, Amgen, AmMax Bio, Amneal Pharmaceuticals, Amolyt Pharma, ANANDA Scientific, Anchiano Therapeutics, Anergis, Angelini Pharma, Angle, Anima Biotech, Antares Pharma, Antengene, Apellis Pharmaceuticals, Applied DNA Sciences, Apricity Health, Aptorum Group, Aqemia, Aqilion, Araris Biotech, Arbor Biotechnologies, Arbutus, ARCA Biopharma, Arcellx, Arcturus Therapeutics, Arcus Biosciences, Ardelyx, Arecor, Arecor Therapeutics, Arena Pharmaceuticals, Ares Genetics, argenx, Argo Biopharma, Ariceum Therapeutics, Aridis Pharmaceuticals, Aristea Therapeutics, Arkuda Therapeutics, Arovella Therapeutics, Arrakis Therapeutics, ArriVent Biopharma, Arrowhead Pharmaceuticals, Arsenal Biosciences, Artios Pharma, Artisan Bio, Artiva Biotherapeutics, Artizan Biosciences, Aruvant Sciences, Asahi Kasei, Ascentage Pharma, ASC Therapeutics, Asep Medical, Asher Bio, Asieris Pharmaceuticals, ASKA Pharmaceuticals, Asklepios Biopharmaceutical, Aslan Pharma, Assembly Biosciences, Astellas Institute for Regenerative Medicine, Astellas Pharma, Astellas Pharma US, Astex Pharmaceuticals, AstraZeneca, ATAI Life Sciences, Atara Biotherapeutics, Atavistik Bio, Ateria Health, Athebio, Atlantic Medical International, Atossa Therapeutics, Atreca, Attralus, AuraVax Therapeutics, Aurigene Discovery Technologies, Aurora Cannabis, Autolus, Autolus Therapeutics, Avacta, Avenzo Therapeutics, AVEO Oncology, AviadoBio, Avicenna Biosciences, Avita Therapeutics, Avrobio, Axolabs, Aytu BioPharma, Aziyo Biologics, Azura Ophthalmics, BASE10 Genetics, Basilea Pharmaceutica, Battelle, Bausch & Lomb, Bausch Health Companies, Baxalta, Baxter International, Bayer, Bayer CropScience, Baylor College of Medicine, Baylor Scott and White Research Institute, Beacon Therapeutics, Beam Therapeutics, BeiGene, Belgian Society of Medical Oncology, Belharra Therapeutics, Bellicum Pharmaceuticals, BeOne Medicines, BGN Technologies, Bicycle Therapeutics, Bill and Melinda Gates Foundation, Bintai Kinden, Bio-Rad Laboratories, Bio-Thera Solutions, bioAffinity Technologies, BioAge Labs, BioArctic AB, biOasis Technologies, Biobeat, Biocaptiva, BioCardia, Biocept, Biocytogen, Biodesix, Biodextris, Biogen, Biohaven Pharmaceuticals, BioInvent, Biolojic Design, BioMarin Pharmaceutical, Biomedical Advanced Research and Development Authority, BioMotiv, Biomunex Pharmaceuticals, BiomX, Biond Biologics, BiondVax, Bioniz Therapeutics, BioNova Pharmaceuticals, BioNTech, BioNuclear, Biorchestra, BioSig Technologies, Biosplice, Biotheus, Biotricity, BioVaxys, BioVersys, Bit Bio, Blackrock Microsystems, Bliss Biopharmaceutical, Bloom Science, Bluebird Bio, Blue Earth Diagnostics, Blueprint Medicines, BlueRock Therapeutics, Boehringer Ingelheim, Bohai Biomedical, Bold Therapeutics, Bolt Biotherapeutics, Boston Immune Technologies and Therapeutics, Boston Pharmaceuticals, Boston Scientific, Brammer Bio, BriaCell Therapeutics, BridgeBio Pharma, BrightPath Biotherapeutics, Bright Peak Therapeutics, Bristol-Myers Squibb, Bruker, Bruno Farmaceutici, Byondis, C4 Therapeutics, C4X Discovery, Cabaletta Bio, Caelum Biosciences, Calder Biosciences, Califia Pharma, Camurus, CanAm Bioresearch, CANbridge Pharmaceuticals, Cancer Genetics, Cancer Research UK, Cannabix Technologies, Cannassure Therapeutics, Capsida Biotherapeutics, Captor Therapeutics, Caraway Therapeutics, Cardiff Oncology, Cardiovascular Systems, Caribou Biosciences, Caris Life Sciences, Carisma Therapeutics, Carmine Therapeutics, Carnegie Mellon University, CARsgen, Cartography Biosciences, Case Western Reserve University, Catalent, Catalyst Pharmaceuticals, CathWorks, CBD Solutions, Celcuity, Celgene, Cellares, Cellectis, Cellenkos, Cellistic, Celltrion, Cellular Biomedicine, Celmatix, Celsius Therapeutics, Century Therapeutics, Cernostics, Cerveau Technologies, Cevec Pharmaceuticals, Champions Oncology, Chansu Vascular Technologies, Charles River Laboratories, CHARM Therapeutics, Checkmate Pharmaceuticals, Checkpoint Therapeutics, Chemify, Chi-Med, Chiesi Farmaceutici, Children's Hospital Boston, Children's Medical Research Institute, Chimeric Therapeutics, Chimeron Bio, Cholesgen, ChromaCode, Chroma Medicine, Chrysalis BioTherapeutics, Chugai Pharmaceutical, CiMaas, Cimeio Therapeutics, Citius Pharmaceuticals, City of Hope, Clavius Pharmaceuticals, Clearmind Medicine, ClearPoint Neuro, Clearside Biomedical, Cleveland Clinic, Clover Biopharmaceuticals, Coalition for Epidemic Preparedness Innovations, Cocoon Biotech, Code Biotherapeutics, Codexis, Codiak BioSciences, Coeptis Pharmaceuticals, Coeptis Therapeutics, CohBar, Coherus Biosciences, CoImmune, Collplant, Columbia University, Combotope Therapeutics, Comera Life Sciences, Conatus Pharmaceuticals, Conduit Pharmaceuticals, Confo Therapeutics, Congruence Therapeutics, Contera Pharma, Context Therapeutics, Contineum Therapeutics, ContraFect, Convelo Therapeutics, COPAN, Corvia Medical, COUR Pharmaceutical, Coya Therapeutics, Creatus Biosciences, Crescendo Biologics, CRISPR Therapeutics, CrossBay Medical, Cryolife, CSIRO, CSL, CSL Behring, CSPC Pharmaceutical Group, CStone Pharmaceuticals, Cue Biopharma, Cugene, Cullgen, Cullinan Oncology, Curasight, CUREator, CureVac, Cureverse, Curis, Cutera, Cybeats Technologies, Cyclica, Cyclo Therapeutics, CYduct Diagnostics, Cynata Therapeutics, Cyntar Ventures, Cypris Medical, Cyrano Therapeutics, Cystic Fibrosis Foundation, Cytiva, Cytocom, CytomX Therapeutics, CytoSite Bio, CytoVale, CYTOVIA Therapeutics, Daewoong Pharmaceutical, Daiichi Sankyo, Dana-Farber Cancer Institute, Dartmouth College, Dayra Therapeutics, Debiopharm, Decibel Therapeutics, Deciphex, Deep Genomics, Defence Research and Development Canada, Defence Therapeutics, Deinove, Dementia Discovery Fund, Denali Therapeutics, Denovo Biopharma, Department of Defense, Department of Veterans Affairs, Dermata Therapeutics, Dermelix Biotherapeutics, Dermira, Deverra Therapeutics, Devyser Diagnostics, Dewpoint Therapeutics, Dicerna Pharmaceuticals, DiNAQOR, Dispatch Bio, DNA Link, Door Pharmaceuticals, DotBio, Dr. Reddy's Laboratories, Dragonfly Therapeutics, Dren Bio, Drug Farm, DS Biopharma, DSM, DualityBio, Duke University, Dunad Therapeutics, Durect, Dyadic International, Dynacure, Dyno Therapeutics, DynPort Vaccine Company, Eagle Pharmaceuticals, Eckert & Ziegler, Edesa Biotech, Editas Medicine, Edwards Lifesciences, eFFECTOR Therapeutics, Eisai, Elanco, Eledon Pharmaceuticals, Elektrofi, Element Biosciences, Eligo Bioscience, Eli Lilly, Elpiscience, Elsie Biotechnologies, Emendo Biotherapeutics, Emergence Therapeutics, Emmaus Life Sciences, Emory University, Empirico, EMTensor, Enalare Therapeutics, Enara Bio, Endospan, Energesis Pharmaceuticals, Enesi Pharma, Enigma Biomedical, Enveric Biosciences, EnWave, Enzychem Lifesciences, Enzyvant Science, EpicentRx, eQcell, EQRx, Equillium, ErVimmune, Escugen, ESSA Pharma, Eterna Therapeutics, Eurocine Vaccines, European Biomedical Research Institute of Salerno, Evaxion Biotech, Everads Therapy, Everest Medicines, Evofem Biosciences, EvolveImmune Therapeutics, Evon Medics, Evopoint Biosciences, EVOQ Therapeutics, Evotec, Evox Therapeutics, Evozyne, EVQLV, Exacis Biotherapeutics, Exelixis, Exeltis, Exicure, Exopharm, ExpreS2ion Biotechnologies, Exscientia, Eyam Vaccines and Immunotherapeutics, EyePoint Pharmaceuticals, F-Star Therapeutics, Fabric Genomics, Facit, FairJourney Biologics, Farapulse, Fate Therapeutics, Fauna Bio, Felix Biotechnology, Ferring Pharmaceuticals, Fibrogen, FightMND, FivepHusion, Flagship Pioneering, Flare Therapeutics, Florida State University, Forge Therapeutics, Formycon, Fortis Therapeutics, Fosun Pharmaceutical, Fred Hutchinson Cancer Research Center, Frontier Medicines, FSD Pharma, FUJIFILM Cellular Dynamics, Fusion Pharmaceuticals, Fuzionaire Radioisotope Technologies, Gadeta, Galapagos, Galderma, Gamida Cell, GC Cell, GC Pharma, Gedeon Richter, GEMMA Biotherapeutics, GenEdit, Genentech, General Inception, Generation Bio, Generex Biotechnology, Genesis Therapeutics, GeneTx Biotherapeutics, Genevant Sciences, GenFleet Therapeutics, Genialis, Genmab, Genocea Biosciences, Genome and Company, Genome Biologics, GenomeSmart, Gensaic, Genzyme, George Washington University, German Cancer Research Center, Gicell, Gilead Sciences, Gilgamesh Pharmaceuticals, Glaukos, Global Alzheimer's Platform (GAP), Global Blood Therapeutics, Global Cancer Technology, Global Coalition for Adaptive Research, Glycotope Biotechnology, Glytherix, Goldfinch Bio, Gossamer Bio, Grail, Graphite Bio, Graviton Bioscience, Greenwich LifeSciences, Gritstone Bio, GSK, Gurnet Point Capital, GV20 Therapeutics, Gyroscope Therapeutics, Hadassah Medical Center, HanchorBio, Hansa Biopharma, Harbinger Health, Harpoon Therapeutics, Harvard Medical School, HavaH Therapeutics, Haystack Oncology, HCW Biologics, Healx, Heartseed, Hebrew University of Jerusalem, Heidelberg Pharma, Helius Medical Technologies, Helmholtz Zentrum Munchen, Helocyte, Henlius Biotech, Hepalys Pharma, HepaTx, Heqet Therapeutics, Herantis, HiFiBio, Hikma Pharmaceuticals, Hillstream BioPharma, Histogen, HitGen, HMNC Brain Health, Hoffmann La Roche, Homology Medicines, Hookipa Pharma, Hopstem Biotechnology, Horizon Therapeutics, Hospital for Sick Children, Hoth Therapeutics, HotSpot Therapeutics, Houston Methodist Research Institute, Huadong Medicine, Hubro Therapeutics, Hummingbird Bioscience, Hutchmed, I-mab, i2O Therapeutics, IASO Biotherapeutics, Icagen, Icahn School of Medicine at Mount Sinai, Iconic Therapeutics, Iconovo, IDEAYA Biosciences, Idorsia, IFM Therapeutics, IGAN Biosciences, Ikarovec, Iksuda Therapeutics, Iktos, Illumina, Imbrium Therapeutics, Immatics Biotechnologies, Immix Biopharma, Immuneering, Immune Regulation, Immune System Regulation, ImmuNext, Immunicom, ImmunityBio, ImmunoBiochem, Immunocore, ImmunoGen, Immunome, Immunomic Therapeutics, Immunovia, Immunscape, Immuron, Immusoft, Immutep, IMPACT-AML, Imperial College London, Imugene, Imunon, IMV, In4Derm, Incyclix Bio, Incyte, Indapta Therapeutics, Indivior, InduPro Therapeutics, Infinity Pharmaceuticals, InflammX Therapeutics, iNGENu, Inhibrx, Inmagene Biopharmaceuticals, Innovation Pharmaceuticals, Innovent Biologics, Insilico Medicine, Insitro, InSphero, Inspira Technologies, InspireMD, Inspirna, Institut Curie, Institute for Research in Immunology and Cancer – Commercialization of Research, Institute of Molecular and Clinical Ophthalmology Basel, Institut Pasteur, Intact Therapeutics, Intarcia Therapeutics, Intas Pharmaceuticals, IntelGenx, Intellia Therapeutics, Intellikine, IntoCell, Intract Pharma, iNtRON Biotechnology, Invenra, Inventiva, InxMed, iOncologi, iOnctura, Ionis Pharmaceuticals, IONTAS, IOVaxis Therapeutics, iProgen Biotech, Ipsen, Ironwood Pharmaceuticals, Irras, Isoprene Pharmaceuticals, iSTAR Medical, Italfarmaco, iTeos Therapeutics, ITM Isotopen Technologien, Iveric Bio, Ivy Brain Tumor Center, Jacobio Pharmaceuticals, JanOne, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Jasper Therapeutics, Jazz Pharmaceuticals, JCR Pharmaceuticals, Jiangsu Alphamab, Jiangsu Hansoh Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, JiKang Therapeutics, Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Innovation, Jorna Therapeutics, Joslin Diabetes Center, Jubilant Therapeutics, Junshi Biosciences, Jura Bio, JW Therapeutics, KAHR Medical, Kainos Medicines, Kaken Pharmaceutical, Kalbe Genexine Biologics, KaliVir Immunotherapeutics, Kansas State University, Karolinska University Hospital, Karveer Meditech, KDAc Therapeutics, Kedalion Therapeutics, Kedrion, KeifeRx, Kelonia Therapeutics, Kelun-Biotech Biopharmaceutical, KemPharm, Kezar Life Sciences, Kindeva Drug Delivery, Kindred Bio, Kineta, Kiniksa Pharmaceuticals, KinoPharma, Kiora Pharmaceuticals, Kite Pharma, Klaria, KM Biologics, Know Labs, Krankenhaus Nordwest, KSQ Therapeutics, Kubota Vision, Kukbo, Kura Oncology, Kymera Therapeutics, Kyn Therapeutics, Kyorin Pharmaceutical, Kyowa Hakko Kirin, Kyowa Hakko Kirin Pharmaceuticals, Kyverna Therapeutics, L'Oreal, Laboratoires Thea, Laboratorios Ordesa, Laborie Medical Technologies, La Jolla Institute for Allergy & Immunology, Lantern Pharma, Lantheus Holding, Leap Therapeutics, LegoChem Biosciences, LeMaitre Vascular, LEO Pharma, Les Laboratoires Servier, Leveragen, LG Life Sciences, LianBio, Ligand Pharmaceuticals, Light Chain Bioscience, Likarda, Liminal BioSciences, Lineage Cell Therapeutics, Linnaeus Therapeutics, Lipidor, Lipocine, Liquid Biosciences, Lisata Therapeutics, Livzon Mabpharm, LogicBio Therapeutics, Lovell Government Services, LSU Health Sciences Center, LTS Lohmann Therapie-Systeme, LTZ Therapeutics, Lumen Biomedical, Luminary Therapeutics, Luminostics, Lundbeck, Lupagen, Lupus Therapeutics, Lysogene, Mabylon, Macomics, Macrogenics, Magenta Therapeutics, MAIA Biotechnology, Mainz Biomed, Mainz University Medical Centre, Mallinckrodt Pharmaceuticals, Mammoth Biosciences, Manhattan BioSolutions, MannKind Biopharmaceuticals, Marengo Therapeutics, Maruho, Masimo, Massachusetts General Hospital, Massachusetts Institute of Technology, Matchpoint Therapeutics, Matinas Biopharma, MaveriX Oncology, Max-Planck, Mayo Clinic, MC2 Therapeutics, McQuade Center for Strategic Research and Development, MD Anderson Cancer Center, MD Matrix, Medical City North Hills, Medical College of Georgia, Medical Technology Enterprise Consortium, Medical University South Carolina, Medice Arzneimittel Pütter, MEDiC Life Sciences, Medicure, Medidata Solutions, MediGene, MediLink Therapeutics, Medtronic, MeiraGTx, Melior Pharmaceuticals, Memorial Sloan Kettering Cancer Center, Memo Therapeutics, Menarini, Merck and Co, Merck Animal Health, Merck KGaA, Merck Sharpe & Dohme, Merdury Biopharmaceutical, Mersana Therapeutics, Merus, Merz, Mesoblast, Mestag Therapeutics, Metagenomi, MetVital, Microbot Medical, MicroQuin, Millennium, MiMedx, Mimetas, MiNA Therapeutics, MindBio Therapeutics, MindPeak, MiNK Therapeutics, Mirati Therapeutics, Mirimus, Mirror Biologics, miR Scientific, Mirum Pharmaceuticals, Mitokinin, Mitsubishi Chemical, Mitsubishi Tanabe Pharma, MockV Solutions, Moderna, Modulus Discovery, Molecular Partners, Molecular Templates, Moleculin Biotech, Molecure, MOMA Therapeutics, Monopar Therapeutics, Monte Rosa Therapeutics, Morphic Therapeutic, MorphoSys, Mor Research Applications, Mosaic ImmunoEngineering, MSD, MS Pharma, Multimmune, Multiply Labs, Mundipharma, Munich Technical University, Murdoch Childrens Research Institute, MustGrow Biologics, MycoMedica Life Sciences, Mydecine Group, Myeloid Therapeutics, Myeloma Investment Fund, Mymetics, myNEO, Myovant Sciences, Myriad Genetics, Myricx Bio, Nacuity Pharmaceuticals, Nanjing Leads Biolabs, Nanoform, NanoViricides, Nantes University, Napo EU, Napo Pharmaceuticals, National Cancer Institute, National Comprehensive Cancer Network (NCCN), National Institute of Allergy and Infectious Diseases, National Institute of Neurological Disorders and Stroke, National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health, Nationwide Children’s Hospital, Navitor Pharmaceuticals, NBE Therapeutics, NEC, Nectin Therapeutics, Nektar Therapeutics, Nelum Pharma, Nemysis, NeoDynamics, NeoImmuneTech, Neomorph, Neotope, Nerviano Medical Sciences, Nestle Health Science, NeuBase Therapeutics, NeuExcell, Neumentum, NeuraLight, Neuraly, NeurAxis, Neuraxpharm, Neurgain Technologies, Neuro3 Therapeutics, Neurocrine Biosciences, NeuroFront, Neurogene, NeurOp, Neurophth Therapeutics, NeuroRx, NeuroSense Therapeutics, Newron Pharmaceuticals, Neximmune, NextCure, Next Science, Nicox, Nightingale Health, Nihon Medi-Physics, Nimble Therapeutics, Nippon Shinyaku, NJ Bio, Nkarta Therapeutics, NLS Pharmaceutics, Nona Biosciences, Nordic Nanovector, NorthBay Healthcare, North Carolina State University, Nosis Biosciences, Novaremed, Novartis, Novellus Therapeutics, Novocure, Novo Nordisk, Novosound, nRichDX, Nuance Pharma, Nucleix, Numab, NuProbe, Nurix Therapeutics, Nutriband, Nuvectis Pharma, Nuvothera, NYU Grossman School of Medicine for Preclinical and Clinical Research, NYU Langone Medical Center, Obsidian Therapeutics, Ohara Pharma, OKYO Pharma, Olema Oncology, OliX Pharmaceuticals, Omega Laboratories, Omega Therapeutics, Ona Therapeutics, OncoArendi Therapeutics, Oncoceutics, OncoCyte, Oncodesign, OncoHost, Oncology Venture, Oncolytics Biotech, OncoMyx Therapeutics, OncoNano Medicine, OncoSec Medical, OncoVent, Oncovir, ONK Therapeutics, OnKure, Ono Pharmaceutical, Onward Therapeutics, Opsis Therapeutics, Optellum, Optieum Biotechnologies, Orbis Medicines, Orbit Biomedical, Orchestra BioMed, Orexo, Organon, ORIC Pharmaceuticals, Orient EuroPharma, Origami Therapeutics, Orion, Orion Biotechnology, Orna Therapeutics, Ortho Regenerative Technologies, Ortoma, Orum Therapeutics, OSE Immunotherapeutics, Osivax, Ossianix, Otsuka, Ovensa, Ovid Therapeutics, Oxford BioMedica, Oxford Biomedica Solutions, Oxford BioTherapeutics, Oyster Point Pharma, Palleon Pharmaceuticals, Panbela Therapeutics, Pandion Therapeutics, Pantherna Therapeutics, Papyrus Therapeutics, Paragon Genomics, Passage Bio, Path BioAnalytics, Pathogen and Microbiome Institute, PAVmed, PDC*line Pharma, Pearl Bio, PEAR Therapeutics, PeptiDream, Personalis, PersonGen BioTherapeutics, Pfenex, Pfizer, PharmaEngine, PharmaTher, Pharming Group, PHAXIAM Therapeutics, Phenomic AI, Philogen, Phio Pharmaceuticals, Phost’in Therapeutics, PierianDx, Pieris Pharmaceuticals, Pierre Fabre, PineTree Therapeutics, Pionyr Immunotherapeutics, Plexium, Plus Therapeutics, PolyNovo Biomaterials, Polyphor, Poolbeg Pharma, Portage Biotech, Poseida Therapeutics, Praxis Precision Medicines, Precision BioSciences, Prellis Biologics, Prelude Therapeutics, Presage Biosciences, Prevail Therapeutics, Prime Medicine, Processa Pharmaceuticals, ProfoundBio, ProFound Therapeutics, Progenity, Prokarium, ProMed Pharma LLC, Proscia, Protalix BioTherapeutics, Proteomics International, Proteovant Therapeutics, Prothena, Provention Bio, Providence Therapeutics, Provista Diagnostics, Psycheceutical Bioscience, Puerto Rico Government, Pulmatrix, Puma Biotechnology, Purdue Pharma, Purespring Therapeutics, PureTech Health, Purple Biotech, Q32 Bio, QBiotics, QIAGEN, Qualigen, QuantalRF, Quantum Leap Health Care Collaborative, Quebec Consortium for Drug Discovery, Queensland Institute of Medical Research (QIMR), Queensland University of Technology, Quell Therapeutics, Quoin Pharmaceuticals, Quris-AI, R-Pharm, Rabin Medical Center (Beilinson Hospital), Race Oncology, Radiance Biopharma, Radionetics Oncology, Radiopharm Theranostics, Rafael Pharmaceuticals, Ragon Institute, Rallybio, Rani Therapeutics, RayzeBio, Recce Pharmaceuticals, Recludix Pharma, ReCode Therapeutics, Recursion, RedHill Biopharma, RefleXion Medical, Regeneron Pharmaceuticals, Regenxbio, Regional Cancer Institute of Montpellier, Regor Therapeutics, Regranion, Relay Therapeutics, Relief Therapeutics, Remedium Bio, Remix Therapeutics, ReNAgade Therapeutics, RenalytixAI, ReNeuron, Renovaro BioSciences, Repare Therapeutics, Replicel Life Sciences, Respira Therapeutics, RespireRx Pharmaceuticals, Revance Therapeutics, ReviR Therapeutics, ReVision Optics, Revitope Oncology, ReviveMed, Revive Therapeutics, RevolKa, Revolution Medicines, Rgenta Therapeutics, Rheos Medicines, Ribometrix, Riparian Pharmaceuticals, Ripple Therapeutics, Roche, Rockwell Medical, Roivant Sciences, Rona Therapeutics, Roswell Park Cancer Institute, RQ Biotechnology, RS BioTherapeutics, RubrYc Therapeutics, Rumpus Therapeutics, Rune Labs, Ryvu Therapeutics, SAB Biotherapeutics, Saga University, Sairopa, Salipro Biotech, Samsung Bioepis, Samyang Biopharmaceuticals, SanegeneBio, Sangamo Therapeutics, Sanofi, Sanofi US Services, Santen Pharmaceutical, Santhera Pharmaceuticals, Sant Joan de Déu-Barcelona Children’s Hospital, Sapphiros, Sarah Cannon Research Institute, Sarepta Therapeutics, Schrodinger, SciClone Pharmaceuticals, SciNeuro Pharmaceuticals, Scintomics, Scipher Medicine, Scorpion Therapeutics, Scribe Therapeutics, Scripps Research Institute, Scynexis, Seagen, Seattle Genetics, Secarna Pharmaceuticals, Second Genome, Selecta Biosciences, SELLAS Life Sciences Group, Senda Biosciences, SEngine Precision Medicine, Senhwa Biosciences, Senju Pharmaceutical, Sensorion, Senti Biosciences, Sentinel Oncology, Seres Therapeutics, Sernova, Serum Institute of India, Seven and Eight Biopharmaceuticals, Seyltx, Shanghai Fosun Long March Medical Science, Shanghai Medicilon, Shape Therapeutics, Shattuck Labs, Shenzhen Chipscreen Biosciences, Shionogi, Shionogi Pharma, Shoreline Biosciences, Signet International, Signet Medical Solutions, Silence Therapeutics, Silk Road Therapeutics, Silo Pharma, SimBioSys, Simcere Pharmaceuticals, Simcha Therapeutics, Singular Genomics Systems, Sinntaxis, Sironax, Sirtex Medical, SiSaf, Sixty Degrees Pharmaceuticals, SK Biopharmaceuticals, Skye Bioscience, Skyhawk Therapeutics, SkylineDX, Sofregen Medical, Solid Biosciences, Soligenix, Sona Nanotech, Sonnet BioTherapeutics, Sonoma BioTherapeutics, Sorrento Therapeutics, Sosei, Sosei Heptares, SOTIO, Sovargen, Spark Therapeutics, Sparrow Pharmaceuticals, Spear Bio, Spectral AI, Spectral Medical, Spencer Health Solutions, Spherix, SpikImm, SpineThera, SpliceBio, Spring Bank Pharmaceuticals, SpringWorks Therapeutics, Spruce Biosciences, Stablepharma, STADA Arzneimittel, Stahl, Stallargenes, Starpharma, Statera Biopharma, State University of New York, Stealth BioTherapeutics, Stemline Therapeutics, StemoniX, St George Street Capital, Stora Enso, Storm Therapeutics, Strand Therapeutics, StrideBio, Structured Monitoring Products, Stuart Therapeutics, SUDA Pharmaceuticals, Sumitomo Corporation, Sumitomo Dainippon Pharma, Sumitovant Biopharma, Summit Therapeutics, SunRock Biopharma, SunTech Medical, Supernus Pharmaceuticals, Sutro Biopharma, Suzhou NeuPharma, SwanBio Therapeutics, Swedish Orphan Biovitrum, Syena, Symvivo, Synaffix, Syndax Pharmaceuticals, SynerK, Synlogic, Synthekine, Synthetic Biologics, Syros Pharmaceuticals, T2 Biosystems, Tachyon Therapeutics, Taiho, Taisho Pharmaceutical, Taiwan Liposome Company, Takeda Pharmaceutical, Takeda Pharmaceuticals U.S.A, Takeda Ventures, Talem Therapeutics, Talix Therapeutics, TARA Biosystems, Targovax, Tautomer Bioscience, Tavros Therapeutics, Taysha Gene Therapies, TB Alliance, Teitur Trophics, TekCyte, Tela Bio, Telix Pharmaceuticals, Tempest Therapeutics, Tempus, TeneoBio, TeneoOne, Tentarix Biotherapeutics, Terray Therapeutics, Terumo, Tetra Bio-Pharma, Tetragenetics, Teva Pharmaceutical Industries, Texas A&M University, Texcell, TFF Pharmaceuticals, TG Therapeutics, Tharimmune, Theragnostics, Theralase, Therapix Bio, Theriva Biologics, Thermo Fisher Scientific, Third Arc Bio, Thirona Bio, Thomas Jefferson University, Tiba Biotech, Titan Pharmaceuticals, TiumBio, Tivic Health Systems, Tizona Therapeutics, TNI Medical, Todos Medical, Tome Biosciences, TONIX Pharmaceuticals, Torii Pharmaceutical, Torque Therapeutics, Totus Medicines, Toxys, TRACON Pharmaceuticals, TransCode Therapeutics, Transgene, Transition Bio, TransThera, TreeFrog Therapeutics, Trevena, Treventis, TRexBio, TRIANA Biomedicines, Trio Pharmaceuticals, Triphase Accelerator, TriSalus Life Sciences, TRT Innovations, Trutino Biosciences, TScan Therapeutics, TTC, Tubulis, Tufts Medical Center, Tufts University, TuHURA Biosciences, Turnstone Biologics, Twist Bioscience, Tyris Therapeutics, Ubiquigent, Ubix Therapeutics, UCB, Ultragenyx Pharmaceuticals, Umoja Biopharma, Undisclosed Company, Uni-Bio Science, Unilever, UNION Therapeutics, Uni Targeting Research, UnitedHealth, Univercells, Universite Laval, University College Cork, University College London, University Gottingen, University of Alberta, University of Amsterdam, University of Bonn, University of British Columbia, University of California San Francisco, University of Colorado, University of Edinburgh, University of Florida, University of Houston, University of Kentucky, University of Lausanne, University of Leipzig, University of Leuven, University of Louisville, University of L’Aquila, University of Maryland Baltimore, University of Massachusetts, University of Massachusetts Medical School, University of Melbourne, University of Michigan, University of Montreal, University of North Carolina, University of Oxford, University of Pennsylvania, University of Pittsburgh, University of Sheffield, University of Southern California, University of Texas Medical Branch, University of Texas Southwestern Medical Center, University of the Highlands and Islands, University of Tubingen, University of Virginia, University of Wisconsin, University of Wisconsin-Madison, University of Wollongong, Unnatural Products, UroGen Pharma, Urotronic, Urovant Sciences, UT Southwestern Medical Center, UWM Research Foundation, Valencell, ValenzaBio, Valo Therapeutics, Vanderbilt University, VantAI, Variational AI, Vaxart, Vaxcyte, Vaximm, Vect-Horus, VectivBio, VectorBuilder, VectorY Therapeutics, VelaVigo, VenatoRx, Vensica Medical, Ventyx Biosciences, Verastem, Verge Genomics, VerImmune, Vernalis, Verrica Pharmaceuticals, Vertex Pharmaceuticals, Verve Therapeutics, Vesalius Therapeutics, Vetophage, Viatris, VIB, Vici Health Sciences, Victoria University, ViGeneron, Vigil Neuroscience, Vir Biotechnology, Vitalli Bio, Vivace Therapeutics, Vivet Therapeutics, Vividion Therapeutics, vivoPharm, Vivoryon Therapeutics, Vivtex, Voluntis, Vor Biopharma, Voyager Therapeutics, VyGen-Bio, VYNE Therapeutics, Vyriad, Washington University in St Louis, WaVe Lifesciences, WAVE Life Sciences, Weizmann Institute, Westchester Medical Center Health Network, Westport Bio, Wisconsin Alumni Research Foundation, Wistar Institute, Worldwide Clinical Trials, WuXi Biologics, WY Biotech, X-chem, Xencor, Xenetic Biosciences, Xenon Pharmaceuticals, XERIS Pharmaceuticals, Xiamen Amoytop Biotech, Xilio Therapeutics, Xoma, Xyphos Biosciences, Y-Biologics, Y2X Life Sciences, Yale University, Yeda Research and Development Company, Yield10 Bioscience, Yissum Research Development, ZAI Laboratory, Zambon, Zealand Pharma, ZebiAI Therapeutics, Zelgen, Zenith Epigenetics, Zenyaku Kogyo, Ziopharm Oncology, Zomedica, Zosano Pharma, Zymeworks

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.